as presented by dr Sartor at ESMO 2024
177Lu-PNT2002 improves OS compared to... - Advanced Prostate...
177Lu-PNT2002 improves OS compared to ARPIs in metastatic castration resistant prostate cancer
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
177Lu-PNT2002 Significantly Improves rPFS Vs ARPI in Metastatic Castration-Resistant Prostate Cancer
https://www.onclive.com/view/177lu-pnt2002-significantly-improves-rpfs-vs-arpi-in-metastatic-castrat
FDA Grants Fast Track Designation for 177Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Is this superior to the LU177 now available?...
New guidelines to prevent skeletal events in metastatic prostate cancer
They are basically discussing denosumab and zoledronic acid in PCa with bone metastasis...
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer
I read about Rusland experience with tandem theraphy.
Does anyone know if this type of tandem...
Treatment After Progression in Metastatic Castration-Resistant Prostate Cancer: some options
Interesting perspective, but we need more weapons still!...
Apalutamide for Metastatic Castration-Sensitive Prostate Cancer
METASTATIC RESISTANT PROSTATE CANCER (Spine And Ribs)
Metastatic prostate cancer 
prostate cancer metastatic
Metastatic Prostate Cancer
